NDC 0121-1016 – Atovaquone

Atovaquone 750 mg/5mL · Suspension · Oral

Human Prescription Drug

Product NDC0121-1016

Product details

Brand name
Atovaquone
Generic name
Atovaquone
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
Suspension
Route
Oral
Marketing category
ANDA · ANDA214272
Marketed since
January 10, 2024
Listing expires
December 31, 2027
Pharmacologic class
Antimalarial; Antiprotozoal

Active ingredients

Uses, dosage, side effects and warnings for Atovaquone →

Package NDC codes (2)

Package NDCDescriptionSince
0121-1016-183 TRAY in 1 CASE (0121-1016-18) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)Jan 10, 2024
0121-1016-427 TRAY in 1 CASE (0121-1016-42) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)Jan 10, 2024

Other Atovaquone products